The Food and Drug Administration on Tuesday authorized e-cigarettes for the first time, saying data submitted by R.J. Reynolds indicates the company's Vuse digital vapor cigarette could help adults who are trying to quit or cut down on smoking.
This decision only applies to Vuse's refillable Solo Power devices and nicotine cartridges that are tobacco flavored. The FDA said R.J. Reynolds requested authorization of other flavored products, and those petitions were rejected. Last month, the FDA said it denied applications for more than 1 million e-cigarettes and associated products, primarily because they could appeal to minors, The Associated Press reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Amazon's 'James Bond' deal could mean a new future for 007In the Spotlight The franchise was previously owned by the Broccoli family
-
Why are Republicans suddenly panicking about DOGE?TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
-
What is JD Vance's Net Worth?In Depth The vice president is rich, but not nearly as wealthy as his boss and many of his boss' appointees
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
-
Bird flu one mutuation from human threat, study findsSpeed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
-
Dark chocolate tied to lower diabetes riskSpeed Read The findings were based on the diets of about 192,000 US adults over 34 years
